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ABSTRACT
Breast cancer is prevalent in Ethiopia that accounts 34% among women cancer
patients. The diagnosis technique in Ethiopia is manual which was proven to be
tedious, subjective, and challenging. Deep learning techniques are revolutionizing
the field of medical image analysis and hence in this study, we proposed Con-
volutional Neural Networks (CNNs) for breast mass detection so as to minimize
the overheads of manual analysis. CNN architecture is designed for the feature
extraction stage and adapted both the Region Proposal Network (RPN) and
Region of Interest (ROI) portion of the faster R-CNN for the automated breast
mass abnormality detection.
Our model detects mass region and classifies them into benign or malignant
abnormality in mammogram(MG) images at once. For the proposed model,
MG images were collected from different hospitals, locally.The images were
passed through different preprocessing stages such as gaussian filter, median
filter, bilateral filters and extracted the region of the breast from the back-
ground of the MG image. The performance of the model on test dataset is found
to be: detection accuracy 91.86%, sensitivity of 94.67% and AUC-ROC of 92.2%.
Keywords: Breast cancer, Digital Mammography, Deep Learning, Convolutional
Neural Network, Object Detection, Mass Detection, Benign, Malignant.
1 INTRODUCTION
Breast cancer is one of the most common cancer and cause of death among women globallyTrimble
(2017); Organization et al. (2006); Mutebi & Edge (2014). According to the global cancer statics,
the number of new cases in 2018 was estimated to be 18,078,957 and deaths 9,555,027 (52.85%)
globally Bray et al. (2018). The cases of breast cancer amounts to 2,088,849 (11.55%) and the deaths
is estimated to be 626,679 (6.56%). 60% of the deaths occur in low income developing countries
like Ethiopia Bray et al. (2018); Hadgu et al. (2018); Vanderpuye et al. (2019); Stefan (2015).Studies
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show that cancer diagnosis in Ethiopia is time consuming, in some cases it takes three to six months
in order to report a given subject is positive or negative. During this time interval the disease could
reach uncontrollable stage before the cancer is deemed positive and this may lead to lower survival
rate Vanderpuye et al. (2019); Dibisa et al. (2019). Mammography is the golden standard imaging
modality used to detect breast abnormalities at an early stageSree et al. (2011) and hence, micro
calcification and masses are the earliest signs of breast cancer which can only be detected using
imaging modality. The abnormalities may be benign or malignant depending on the invasive stage
of the breast abnormality. Detection of masses in breast tissue is more challenging compared to the
detection of micro calcification Hagos et al. (2018). Early detection of breast cancer has shown a
reduction of mortality rate between 38% to 48% Broeders et al. (2012). However, manual mammo-
gram analysis and interpretation leads to 10% - 30% misdiagnosis error rates Oeffinger et al. (2015);
Kerlikowske et al. (2000).
Lack of early detection leads to thousands of women go through painful, lower survival rate and
scar inducing surgeries. To mitigate this and similar challenges many studies have been undertaken
using both conventional machine learning and deep learning based methods.
Recently, due to huge amount of data, high computational power of Graphical Processing Units
(GPUs), deep Learning has shown promising success in natural language processing Iyyer et al.
(2015), object detection and recognition Goodfellow et al. (2016) and medical image analysis Shen
et al. (2017); Greenspan et al. (2016); Ben-Ari et al. (2017). Deep learning based methods are sensi-
tive to image acquisition setting, scanner types and the image preprocessing applied. Moreover, the
studies by Martin & Weber (2000); Organization et al. (2006) showed that the evolution of breast
cancer can be shaped by race, geographical location, and other risk factors. In this work, we pro-
posed convolutional neural network(CNN) based breast mass detection approach to simultaneously
localize and classify the mass into either benign or malignant abnormality. To train, validate and test
the method, datasets were collected from different sites.
Overall, this work has the following contributions:
• Here in Ethiopia, we had experienced a hard time in searching and collecting the required
dataset. Hence, we have collected the dataset that will be useful as a starting point for
researchers who will be working in the area.
• An automated breast mass abnormality detection model was developed that detects and
localizes mass regions and classifies them into benign or malignant in MG images.
2 METHODOLOGY
2.1 ETHICAL STATEMENT AND CONFIDENTIALITY
Ethical clearance was given from College of Health Sciences - Mekelle University, by the Institu-
tional Review Board (IRB) and the ethical review committee of each respective hospitals where data
was collected. Profiles of the patients were removed and anonymised in order not to be identifiable
in any way, and kept the confidentiality of the gathered data with great care.
2.2 DATASET
The dataset was mainly collected from St.Gebriel Hospital, Grum Hospital, Betezatha Hospital, Ko-
rean Hospital, Kadisco Hospital and Pioneer Diagnostic. The MG images were collected with their
document reports that show the screening and diagnosis results of the patients. The documents report
results were based on the pathology confirmation and Breast Imaging-Reporting and Data System
(BI-RADS). More than 5000 x-ray mammogram images that were diagnosed between 2016 and
2018 as shown in table 1 were collected and some of the samples are shown in figure 1. This work
considered only the mass abnormality from the collected MG images, that is 1588 full mammogram
images which have mass abnormality and annotated by professional radiologists using the labelMe
Russell et al. (2008) annotation tool. The dataset was divided into training (80%), validation (10%),
and testing (10%).
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Table 1: List of total collected MG images from different hospitals and the number of MG images
consisting of mass abnormalities for both benign and malignant. In this work, mass abnormality was
considered.
Dataset Source Total patient
cases ( total
MG images)
Total number
of MG images
with mass ab-
normality
Training Validation Testing
St. Gebriel Hospital 580(2224) 800 640 80 80
Grum Hospital 450(1684) 400 320 40 40
Korea Hospital 280(1024) 210 168 21 21
Betezatha Hospital 340(1270) 138 110 14 14
Kadisko Hospital 20(70) 40 32 4 4
Pioneer Diagnostic
Center
20(68) 30 24 3 3
(a) (b) (c)
Figure 1: Sample of MG images during acquisition stage. The mammogram images are from dif-
ferent mammography x-ray sources: (a) from Girum Hospital, (b) from Pioneer Diagnostic Center,
and (c) from St. Gebriel Hopital.
2.3 METHOD
We developed CNN based breast mass abnormality detection model that detects automated region
of interest of mass abnormality and classify them into benign or malignant in MG images. We used
preprocessing and augumentation for the 116 full MG images taken from INbreast Moreira et al.
(2012) and 1380 full MG images taken from CBIS-DDSM Lee et al. (2017) so as to have initial
weights for training our model and the local collected dataset. Overall, our proposed method has
the following steps:
• Data collection: the dataset described in table 1 was collected from different hospitals in
Ethiopia.
• MG image preprocessing: To enhance the quality of the data and prepare it in a suitable
way for deep learning training the data was preprocessed. To remove noise in the images
gaussian filtering, median and bilateral filtering were applied. Later the images were
enhanced using contrast-limited adaptive histogram equalization (CLAHE) and then
followed by morphological operation and OTSUs thresholding to extract the breast region
from the background and to remove non-portion of breast region from the MG such as
artifacts, labels, patient profiles and others.
• Model training: figure 2 shows our proposed breast cancer detection pipeline. The feature
extraction section has a series of five convolutional layers with (64, 128, 256, 512,512 )
number of filters for each convolution layer, respectively. Each convolution layer is fol-
lowed by Relu activation layer, batch normalization, maxpooling layer and dropout except
3
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the second layer which has neither dropout nor maxpooling. Convolution was performed
with a kernel filter of (3,3) , stride of (1,1) and same padding. The max pooling was per-
formed with stride of (2,2) and kernel filter of (2,2). Furthermore, by adapting the anchor’s
bound box scales, ratios of the RPN and maxpooling of the ROI Pooling portion of the
Faster R-CNN Ren et al. (2015), it was employed for the detection of mass abnormalities.
We used 9 anchors with 32 × 32, 64 × 64 and 128 × 128 pixels of anchor box scales
and [1, 1], [1./sqrt(2), 2./sqrt(2)] and [2./sqrt(2), 1./sqrt(2)] of anchors box ratios, and (5,5)
ROI maxpooling size. What is more, 0.9 momentum, 500 epochs, 0.00001 learning rate,
Adam for the RPN and Stochastic Gradient Descent(SGD) for the whole model as opti-
mizers were used. The proposed model was implemented with Python and Keras, where
Tensorflow was used as a backend.
Figure 2: Structure of Breast Cancer Detection architecture flow work. The detection portion of
RPN and ROI pooling are adapted from the Faster R-CNN Ren et al. (2015)
3 RESULT AND DISCUSSION
This paper describes a CNN based approach for detecting mass regions and classifies them into be-
nign or malignant. Here, mass abnormality detection, localization and classification in to benign or
malignant in one process in local multi-center MG data-set is investigated. It is difficult to directly
compare our detection results with previous works, locally. Hence, we have trained, validated and
tested VGG based faster R-CNN Ren et al. (2015) architecture in order to compare with our model’s
performance by using the dataset that was collected. Out of the total collected images, 1588 full
MG images that contain mass abnormalities were selected and then annotated by professional radi-
ologists using the labelMeRussell et al. (2008) annotation tool. In the 1588 MG images there are
1683 number of breast mass abnormalities. The dataset was randomly split into 80% for training,
10% for validation and 10% for testing. We performed the same pipeline preprocessing for INbreast
Moreira et al. (2012), CBIS-DDIS Lee et al. (2017) and collected local MG data-sets for the pro-
posed model and VGG based faster R-CNN. In the preprocessing stage: different imaging formats
such as DICOM medical image format to .png image format were converted, noise was removed,
breast region was extracted from the background, patients’ information were removed, artifacts and
other unwanted objects were cleansed. Gaussian, medium and belaterial filters with 3×3 and 5×5
sizes each were used for noise removal and evaluated the denosied results using MSE. Out of the
two filter sizes considered the one with 3×3 size was finally used. Additionally, CLAHE was used
to enhance the denoised MG images and after that the breast region was extracted and unwanted
artifacts were removed using OTSU and morphological operations.
Four different threshold values such as T=1 (100%), 0.75 (75%), 0.5 (50%) and 0.25 (25%) were
used in the experiments for the Intersection over Union (IoU) overlapping the ground truth bound
box and predictive bound box in the RPN. The IoU overlap are summarized in table 2 for the VGG
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Table 2: VGG based faster R-CNN detection model: IoU over all results with varying overlap
percentage thresholds for the test MG dataset
Overlap threshold T 100% 75% 50% 25%
IoU 28.46% 49.5% 69.25% 88.76%
Table 3: Our proposed detection model: IoU overall results with varying overlap percentage thresh-
olds for the test MG dataset
Overlap threshold T 100% 75% 50% 25%
IoU 36.26% 58.75% 78.34% 94.2%
Table 4: VGG based faster R-CNN detection model performance: over all breast mass abnormality
classification results of MG images.
Evaluation
Metrics
Accuracy Sensitivity (Re-
call)
Specificity Precision AUC-ROC
Results in per-
centage
84.88% 80% 88.65% 84.5% 84.3%
Table 5: The proposed detection model performance: over all breast mass abnormality classification
results in MG images.
Evaluation
Metrics
Accuracy Sensitivity (Re-
call)
Specificity Precision AUC-ROC
Results in per-
centage
91.86% 94.67% 89.69% 87.65 % 92.2%
based faster R-CNN detection model and in table 3 for the proposed detection model. In both mod-
els the IoU score improves as the threshold value decreases. Since the breast mass abnormalities
are very small compared with the natural image objects such as person face, car and other objects in
imagenetDeng et al. (2009). So, the final threshold value is set to T=0.25 which is more suitable to
detect almost all mass abnormalities. The classification result is summarized as shown in table 4
and table 5, and ROC curves are shown in figure 3a and figure 3b for the VGG based Faster R-
CNN and the proposed model, respectively. The result for the Area Under the Curve (AUC) for the
proposed model is (AUC=92.2 %) in taking the right decision taken during the classification than
the AUC of the VGG based faster R-CNN detection model ( AUC= 84.3%). Overall, the proposed
model performs well than VGG based faster R-CNN. The model outperformed because the hyper-
parameters of the designed feature extractor (base network) and the adapted RPN and ROI pooling
detection portion were tweaked. Besides, the model prevents overfitting and internal covariance
shift due to dropout and batch normalization layers in both the base network and RPN in each after
the non-linear activation layers (Relu), respectively. It was observed that there are feature similarity
between the benign and malignant. The reason is that data was collected from different hospitals
under different lighting conditions, scanned using different mammography devices, and other fac-
tors. Hence, VGG based Faster R-CNN detection model misclassified 26 and the proposed model
misclassified 14. Some of the mass abnormality detected from the test dataset by the VGG based
Faster R-CNN and the proposed model are shown in figure 4 (a) and (b), and (c) to (e), respectively.
figure 4 (f) is one of the miss-detected in the MG image by the model. The green bounding boxes in
the figures are showing the detected mass abnormalities. Each detected mass abnormalities contains
bounding box with green color, class name and confidence score.
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(a) (b)
Figure 3: ROC curves of (a) VGG based faster R-CNN model and (b) the proposed model
(a) (b) (c)
(d) (e) (f)
Figure 4: Sample of mass abnormalities (a) to (b) detected by VGG based faster R-CNN model, (c)
to (e) detected and (f) miss-detected by the proposed model.
4 CONCLUSION
The paper presents CNN based breast cancer detection model that detects mass abnormality and
classify them in to benign and malignant in MG. A CNN architecture for feature extraction was
designed as shown in figure 2 and RPN and ROI pooling portion from the faster R-CNN Ren et al.
(2015) for the breast mass abnormality detection was adopted.
The model was trained and evaluated via the MG images. The proposed model achieved detection
accuracy of up to 91.86% , sensitivity of 94.67% and AUC-ROC of 92.2%.
Based on the investigation and findings of the study, the following recommendations are forwarded
for further research works:
• We have only considered breast mass abnormality. So, the study can be extended to include
macro calcification abnormalities that is not considered here.
• By increasing the amount of annotated MG dataset, the performance of the model can be
enhanced.
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